Kenfarb & Co’s Sanofi SNY Stock Holding History

Kenfarb & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$80.4K	Hold	1,500	–	–	0.07%	129
2023 Q2	$80.8K	Hold	1,500	–	–	0.07%	132
2023 Q1	$81.6K	Hold	1,500	–	–	0.07%	128
2022 Q4	$72.6K	Hold	1,500	–	–	0.06%	133
2022 Q3	$57K	Hold	1,500	–	–	0.05%	136
2022 Q2	$77K	Hold	1,500	–	–	0.06%	129
2022 Q1	$77K	Hold	1,500	–	–	0.06%	129
2021 Q4	$75K	Buy	+1,500	New	+$74.2K	0.05%	130

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kenfarb & Co's SNY Position: Q3 2023 in Review

Kenfarb & Co held its Sanofi (SNY) position steady in Q3 2023 at 1,500 shares worth $80.4K. The position accounts for 0.07% of the portfolio, ranked #129.

Kenfarb & Co first reported a position in SNY in Q4 2021 and has held it in 8 quarters since. The position peaked at $81.6K in Q1 2023. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

Kenfarb & Co held 1,500 shares of Sanofi worth $80.4K as of Q3 2023.
Kenfarb & Co left its Sanofi share count unchanged in Q3 2023.
Sanofi made up 0.07% of Kenfarb & Co's portfolio in Q3 2023, its #129 holding.
Kenfarb & Co first reported a position in Sanofi in Q4 2021 and has held it in 8 quarters since.
Kenfarb & Co's Sanofi position peaked at $81.6K in Q1 2023.
696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.